The Autoimmune Protocol and Rheumatoid Arthritis: What the Research Shows

What You’ll Learn in This Article:

• Insights from in-depth interviews with long-term AIP users
• Findings from the first pilot intervention trial
• Early quantitative improvements in pain, fatigue, and sleep
• Implications for patient care, safety, and future research

Together, these studies provide the first scientific foundation for understanding how AIP may support individuals living with rheumatoid arthritis.

From Anecdote to Evidence

Long before research began, many individuals with RA turned to AIP in hopes of reducing symptoms that persisted despite medication. Across online communities and patient networks, AIP became a frequently discussed strategy for managing joint pain, inflammation, and fatigue. Reports of improved mobility, fewer flares, and better energy were common, but lacked scientific validation.

In recent years, that began to change. Early researchers sought to understand how patients were using AIP, what benefits and challenges they experienced, and whether AIP might offer a supportive role in RA management. The first study focused on qualitative insights, followed by the first pilot intervention trial. Although these studies do not assess biomarkers or disease activity scores in depth, they offer valuable early evidence about AIP’s feasibility, safety, and potential symptom benefits.

RA remains one of the autoimmune conditions where patients most actively explore AIP, making this early research an important first step toward understanding how dietary and lifestyle changes may complement conventional treatment.

Study 1: Qualitative Research on Patient Experience (2020)

The first published study examining AIP for RA was conducted by nutritionist and PhD candidate Julianne McNeill in New Zealand (published under Taylor, 2020). Rather than measuring inflammatory markers, the study used qualitative interviews to explore how people with RA implemented AIP, what challenges they encountered, and what benefits they perceived.

Study Design

The study explored the experiences of ten adults living with rheumatoid arthritis—nine women and one man—between the ages of 28 and 60. On average, participants had been following the Autoimmune Protocol for nearly three years, with individual experience ranging from six months to five years.

Rather than focusing on laboratory markers or standardized disease scores, researchers conducted in-depth, 90-minute semi-structured interviews to better understand each participant’s personal journey with AIP. Conversations centered on what initially motivated them to try the protocol, how they implemented it in everyday life, the challenges they encountered, the forms of support that helped them continue, and the changes they perceived over time.

Importantly, the study intentionally recruited individuals who felt they had benefited from AIP. The goal was not to determine whether AIP “worked” in a clinical sense, but to explore what successful, sustained implementation looked like from the patient perspective—and to identify the factors that may support long-term adherence.

Results

Several consistent themes emerged from the interviews. Most participants were first introduced to the Autoimmune Protocol through holistic practitioners or online autoimmune communities. For many, the decision to try AIP was driven by persistent pain, limited function, and a desire for options beyond conventional treatment alone. The hope of reducing daily discomfort and regaining a sense of control over their health served as a powerful motivator.

When it came to implementation, many described choosing a deliberate start date and transitioning relatively quickly into the elimination phase—particularly those experiencing more severe symptoms. While the structure of the protocol provided clarity, participants also acknowledged meaningful challenges. The restrictive nature of the elimination phase was frequently cited as difficult, and several described navigating skepticism, misunderstanding, or dismissive attitudes from friends, family members, or even healthcare providers.

Despite these barriers, nearly all participants emphasized the importance of support. Having at least one encouraging person—a partner, friend, or knowledgeable practitioner—was often described as critical to sustaining the protocol during challenging moments.

Ultimately, pain reduction emerged as the most significant factor in maintaining AIP long term. Participants commonly reported improvements substantial enough that the dietary restrictions felt justified. For many, the perceived benefits outweighed the difficulties, reinforcing their commitment to continuing the approach.

Discussion

This qualitative study provided the first structured exploration of how individuals with rheumatoid arthritis experience the Autoimmune Protocol in real life. Rather than measuring laboratory markers or standardized disease activity scores, the research centered on patient narratives—offering valuable insight into what motivates individuals to begin AIP, what helps them sustain it, and what obstacles they encounter along the way.

Although the study was not designed to evaluate clinical efficacy, participants consistently reported meaningful improvements in pain levels, energy, sleep quality, and overall daily functioning. For many, these changes were substantial enough to influence long-term adherence, even in the face of dietary restrictions and social challenges. These patient-reported outcomes suggest that AIP may influence dimensions of health that matter deeply to individuals living with RA, including quality of life and perceived control over symptoms.

The study also highlighted the importance of preparation, social support, and access to reliable information as key facilitators of success. At the same time, it underscored common barriers—such as the restrictive nature of elimination and social skepticism—that may limit broader adoption or sustainability without guidance.

Importantly, by documenting consistent patterns across participants, this research helped move the conversation beyond anecdote. It established a foundation for future quantitative and intervention-based studies by identifying both the potential benefits worth measuring and the practical considerations necessary for real-world implementation. In this way, the findings laid important groundwork for subsequent pilot trials designed to formally assess feasibility, symptom changes, and clinical outcomes in rheumatoid arthritis.

Study 2: Mixed-Methods Pilot Intervention Study (McNeill et al., 2023)

Building on the qualitative findings, McNeill and colleagues conducted the first pilot intervention evaluating AIP in individuals with RA. This study, abstract published in Medical Sciences Forum in 2023, aimed to explore feasibility, symptom trends, and patient experience.

Study Design

This mixed-methods pilot study, conducted in New Zealand, examined the feasibility and patient experience of implementing the Core Autoimmune Protocol in individuals diagnosed with rheumatoid arthritis. At the time of writing, the research has been published as a conference abstract, meaning that detailed methodology and full results have not yet been released in a peer-reviewed paper. As such, the available information provides an overview of the design and preliminary findings rather than a comprehensive analysis.

Participants with a confirmed diagnosis of rheumatoid arthritis were guided through implementation of the Core AIP elimination phase. The intervention included structured educational sessions and health coaching support designed to improve adherence, provide practical tools, and address common challenges associated with dietary change. This structured framework aimed to replicate real-world clinical application rather than a purely self-directed approach.

The study used a mixed-methods design, combining quantitative and qualitative data collection. Quantitative measures included standardized assessments of pain, fatigue, and sleep—symptoms that significantly impact quality of life in RA. In addition, qualitative interviews were conducted to capture participants’ lived experiences, perceived benefits, barriers, and overall impressions of the protocol. This dual approach allowed researchers to evaluate not only symptom trends but also the personal and practical dimensions of implementation.

Importantly, the study took place during the COVID-19 pandemic. Public health restrictions influenced how educational sessions and coaching support were delivered, likely shifting much of the interaction to remote or virtual formats. The broader context of pandemic-related stress, disrupted healthcare access, and changes in daily routine may also have shaped participants’ experiences, adherence, and symptom patterns. These contextual factors are important to consider when interpreting preliminary findings and assessing generalizability.

While the abstract suggests encouraging trends, full publication of the study will be necessary to evaluate methodology, statistical outcomes, and long-term implications in greater detail.

Results

As reported in the published abstract, preliminary findings suggested improvements in several measured domains over the course of the intervention. Quantitative assessments indicated changes in pain, fatigue, and sleep among participants following implementation of the Core AIP protocol with structured support.

Qualitative interviews conducted as part of the mixed-methods design also identified themes related to participants’ lived experiences. These included perceptions of symptom change as well as reflections on the process of implementing the protocol within the context of daily life.

Because the study has been released in abstract form only, detailed statistical analyses, effect sizes, and biomarker data have not yet been published. As a small pilot study, the findings are considered preliminary and exploratory. Full peer-reviewed publication will be necessary to evaluate the methodology, results, and clinical implications in greater depth.

Discussion

Although early, this study suggests that AIP may be feasible for individuals with RA and may help reduce pain, support energy levels, and improve sleep. These outcomes are particularly relevant for RA, where fatigue and pain often remain challenging even with medication. The mixed-methods design strengthens the findings by aligning subjective improvements with measurable symptom trends.